Abstract
Angiogenesis Food Inhibitors and their Role in Cancer Treatment
Rachna Chhachhi*
Corresponding Author: Rachna Chhachhi, Johns Hopkins University, US.
Revised: July 23, 2024; Available Online: July 23, 2024
Citation: Chhachhi R. (2024) Angiogenesis Food Inhibitors and their Role in Cancer Treatment. BioMed Res J 8(S1): 11.
Copyrights: ©2024 Chhachhi R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 722

    Views & Citations
  • 10

    Likes & Shares
We all know that Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. And Angiogenesis is key to triggering metastasis. The growth of blood vessels provides the primary path where tumor cells migrate from the primary tumor site to enter the circulation and stay hidden at another site. They the wait for the right inputs and environment inside the body to go from dormant to active.

Research and clinical evidence on anti-angiogenesis foods is growing in the arrest of Cancer and metastasis. Specifically, the role of bioactive nutrients in arresting cancer triggers and metastasis triggers has been identified. This abstract will examine anti-angiogenesis Foods and their role along with clinical case studies, to demonstrate the impact of anti-angiogenesis nutrition in management and relief for cancer patients.

Keywords: Angiogenesis, Tumor migration, Metastasis, Cancer management